PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin disease

Lignende værker

• PReS-FINAL-2130-A: Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland
  af: Moraitis, E, et al.
  Udgivet: (2013)
• Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study
  af: Tansley, Sarah L, et al.
  Udgivet: (2014)
• PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
  af: Bellutti Enders, F, et al.
  Udgivet: (2013)
• Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
  af: Tansley, Sarah L., et al.
  Udgivet: (2014)
• 8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis
  af: Gunawardena, H, et al.
  Udgivet: (2008)